Cargando…
Evaluation of prokinetic agents used in the treatment of gastroparesis
Background/Aim: Hospitalizations due to gastroparesis have increased in the last 20 years with limited advancements in pharmacologic therapy. Although therapy primarily consists of prokinetic agents, little is known about their effects on hospital outcomes. The aim of our study was to determine whet...
Autores principales: | Roe, Neil A, Sakaan, Sami, Swanson, Heather, Twilla, Jennifer D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327917/ https://www.ncbi.nlm.nih.gov/pubmed/28265483 http://dx.doi.org/10.1080/21556660.2016.1278546 |
Ejemplares similares
-
Metoclopramide as a prokinetic agent for diabetic gastroparesis: revisiting the risk of Parkinsonism
por: Lai, Chien-Hsu, et al.
Publicado: (2019) -
Efficacy of prokinetic agents in diabetic gastroparesis comparing symptomatology and scintigraphy – An open-label trial
por: Kant, Ravi, et al.
Publicado: (2023) -
Efficacy and Safety of Mecobalamin Combined with Prokinetic Agents in the Treatment of Diabetic Gastroparesis: A Meta-Analysis
por: Yao, Jia, et al.
Publicado: (2021) -
Prokinetic agents in critical care
por: Doherty, Warren L, et al.
Publicado: (2003) -
Therapeutic strategies in gastroparesis: Results of stepwise approach with diet and prokinetics, Gastric Rest, and PEG‐J: A retrospective analysis
por: Strijbos, Denise, et al.
Publicado: (2019)